ReP USP - Resultado da busca

Filtros : "FCF004" "Velasco, Maria Valéria Robles" "Pharmaceutical Development and Technology" Limpar

Filtros

Artigo de periodico
Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention (2015)
Pinheiro, Vanessa Alves; Serikaku, Daniela; Baby, André Rolim ; Velasco, Maria Valéria Robles ; Kaneko, Telma Mary ; Consiglieri, Vladi Olga
Source: Pharmaceutical Development and Technology. Unidade: FCF
Assunto: ANTIFÚNGICOS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Vanessa Alves et al. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pharmaceutical Development and Technology, v. 20, n. 2, p. 197-203, 2015Tradução . . Disponível em: https://doi.org/10.3109/10837450.2013.860544. Acesso em: 16 out. 2024.
APA
Pinheiro, V. A., Serikaku, D., Baby, A. R., Velasco, M. V. R., Kaneko, T. M., & Consiglieri, V. O. (2015). Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pharmaceutical Development and Technology, 20( 2), 197-203. doi:10.3109/10837450.2013.860544
NLM
Pinheiro VA, Serikaku D, Baby AR, Velasco MVR, Kaneko TM, Consiglieri VO. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 2): 197-203.[citado 2024 out. 16 ] Available from: https://doi.org/10.3109/10837450.2013.860544
Vancouver
Pinheiro VA, Serikaku D, Baby AR, Velasco MVR, Kaneko TM, Consiglieri VO. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 2): 197-203.[citado 2024 out. 16 ] Available from: https://doi.org/10.3109/10837450.2013.860544
Artigo de periodico
Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design (2013)
Duque, Marcelo Dutra; Kreidel, Rogério Nepomuceno; Taqueda, Maria Elena Santos ; Baby, André Rolim ; Kaneko, Telma Mary ; Velasco, Maria Valéria Robles ; Consiglieri, Vladi Olga
Source: Pharmaceutical Development and Technology. Unidades: EP, FCF
Subjects: COMPRIMIDOS, CELULOSE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 16 out. 2024.
APA
Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508
NLM
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 out. 16 ] Available from: https://doi.org/10.3109/10837450.2012.693508
Vancouver
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 out. 16 ] Available from: https://doi.org/10.3109/10837450.2012.693508

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024